María O López-Oliva, Ana Mendoza-Cedeño, Korina Peña-Esparragoza, Belén Estébanez-Montiel, Eva Flores-Cabeza, Mario Álvarez-Maestro, Cristina de Castro-Guerin, Lina M León-Machado, Javier Azores-Moreno, Elena González-García, Carlos Jiménez-Martín
{"title":"Clinical Outcomes After Kidney Transplantation From Controlled Donation After Circulatory Death Donors: A Single-Center Observational Study.","authors":"María O López-Oliva, Ana Mendoza-Cedeño, Korina Peña-Esparragoza, Belén Estébanez-Montiel, Eva Flores-Cabeza, Mario Álvarez-Maestro, Cristina de Castro-Guerin, Lina M León-Machado, Javier Azores-Moreno, Elena González-García, Carlos Jiménez-Martín","doi":"10.1016/j.transproceed.2026.09.005","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Controlled donation after circulatory death (cDCD) has become a key strategy to expand the kidney donor pool. The aim of this study was to evaluate the short- and mid-term outcomes of kidney transplantation from these donors in our center, with special attention to the impact of donor age.</p><p><strong>Patients and methods: </strong>We performed a retrospective single-center observational study including all recipients of kidney transplantation from cDCD donors between April 2015 and December 2024. Patients were divided according to donor age: ≥65 years and <65 years. Delayed graft function (DGF), renal function, graft survival, and patient survival were analyzed using Kaplan-Meier curves and Cox regression analysis.</p><p><strong>Results: </strong>A total of 171 recipients were included; 37 (21.6%) received kidneys from donors ≥65 years. DGF was more frequent in recipients of older donors (81.1% vs 49.3%; P = .002), with lower estimated glomerular filtration rate at 1 year (39 vs 52 mL/min). Death-censored graft survival was comparable between both groups (P = .29). Mortality was higher in recipients of donors ≥65 years (21.6% vs 6.7%; P = .013), with lower patient survival (P = .005). In multivariate analysis, recipient age >65 years was the only independent predictor of mortality (HR 3.9; P = .04), whereas eGFR <30 mL/min at 1 year was the only independent predictor of graft loss (HR 7.3; P = .02).</p><p><strong>Conclusion: </strong>Kidney transplantation from elderly cDCD donors provides favorable mid-term outcomes and represents a safe strategy to expand the donor pool.</p>","PeriodicalId":94258,"journal":{"name":"Transplantation proceedings","volume":" ","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation proceedings","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.transproceed.2026.09.005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Controlled donation after circulatory death (cDCD) has become a key strategy to expand the kidney donor pool. The aim of this study was to evaluate the short- and mid-term outcomes of kidney transplantation from these donors in our center, with special attention to the impact of donor age.
Patients and methods: We performed a retrospective single-center observational study including all recipients of kidney transplantation from cDCD donors between April 2015 and December 2024. Patients were divided according to donor age: ≥65 years and <65 years. Delayed graft function (DGF), renal function, graft survival, and patient survival were analyzed using Kaplan-Meier curves and Cox regression analysis.
Results: A total of 171 recipients were included; 37 (21.6%) received kidneys from donors ≥65 years. DGF was more frequent in recipients of older donors (81.1% vs 49.3%; P = .002), with lower estimated glomerular filtration rate at 1 year (39 vs 52 mL/min). Death-censored graft survival was comparable between both groups (P = .29). Mortality was higher in recipients of donors ≥65 years (21.6% vs 6.7%; P = .013), with lower patient survival (P = .005). In multivariate analysis, recipient age >65 years was the only independent predictor of mortality (HR 3.9; P = .04), whereas eGFR <30 mL/min at 1 year was the only independent predictor of graft loss (HR 7.3; P = .02).
Conclusion: Kidney transplantation from elderly cDCD donors provides favorable mid-term outcomes and represents a safe strategy to expand the donor pool.
导论:循环性死亡后控制捐赠(cDCD)已成为扩大肾脏供体池的关键策略。本研究的目的是评估本中心这些供者肾移植的短期和中期结果,特别关注供者年龄的影响。患者和方法:我们进行了一项回顾性单中心观察研究,包括2015年4月至2024年12月期间所有来自cDCD供体的肾移植受体。根据供体年龄分组:≥65岁。结果:共纳入171例受者;37例(21.6%)接受了≥65岁供者的肾脏。DGF在老年供者中更为常见(81.1% vs 49.3%; P = 0.002), 1年时肾小球滤过率较低(39 vs 52 mL/min)。两组之间的死亡审查移植存活率具有可比性(P = 0.29)。≥65岁的供体受体死亡率较高(21.6% vs 6.7%; P = 0.013),患者生存率较低(P = 0.005)。在多变量分析中,受体年龄在50 ~ 65岁之间是死亡率的唯一独立预测因子(HR 3.9; P = .04),而eGFR结论:老年cDCD供者肾移植提供了有利的中期结果,是扩大供者池的安全策略。